Zebra Capital Management LLC boosted its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 58.1% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,188 shares of the pharmacy operator’s stock after acquiring an additional 4,111 shares during the quarter. Zebra Capital Management LLC’s holdings in Walgreens Boots Alliance were worth $612,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Nelson Roberts Investment Advisors LLC purchased a new position in shares of Walgreens Boots Alliance during the 1st quarter valued at approximately $25,000. Meridian Wealth Management LLC purchased a new position in shares of Walgreens Boots Alliance during the 1st quarter valued at approximately $25,000. Weaver Consulting Group purchased a new position in shares of Walgreens Boots Alliance during the 1st quarter valued at approximately $27,000. Sageworth Trust Co purchased a new position in shares of Walgreens Boots Alliance during the 2nd quarter valued at approximately $27,000. Finally, First Interstate Bank boosted its stake in shares of Walgreens Boots Alliance by 228.1% during the 2nd quarter. First Interstate Bank now owns 607 shares of the pharmacy operator’s stock valued at $33,000 after buying an additional 422 shares during the last quarter. Hedge funds and other institutional investors own 59.70% of the company’s stock.
In other Walgreens Boots Alliance news, CAO Marco Patrick Anthony Pagni sold 215,323 shares of the stock in a transaction on Wednesday, August 14th. The stock was sold at an average price of $50.48, for a total value of $10,869,505.04. Following the sale, the chief accounting officer now directly owns 357,851 shares of the company’s stock, valued at $18,064,318.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 15.73% of the stock is owned by company insiders.
Shares of WBA stock traded down $0.74 on Wednesday, hitting $54.10. 242,406 shares of the stock traded hands, compared to its average volume of 4,496,507. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.76 and a quick ratio of 0.37. The company has a market capitalization of $50.57 billion, a PE ratio of 8.98, a PEG ratio of 1.40 and a beta of 0.88. Walgreens Boots Alliance Inc has a 1-year low of $49.03 and a 1-year high of $86.31. The company’s fifty day moving average is $52.39 and its 200 day moving average is $54.76.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $1.47 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.42 by $0.05. Walgreens Boots Alliance had a return on equity of 22.08% and a net margin of 3.53%. The business had revenue of $34.59 billion for the quarter, compared to analyst estimates of $34.52 billion. During the same period in the prior year, the company posted $1.53 EPS. The business’s revenue was up .7% compared to the same quarter last year. As a group, equities research analysts expect that Walgreens Boots Alliance Inc will post 5.98 EPS for the current year.
The business also recently announced a quarterly dividend, which was paid on Thursday, September 12th. Shareholders of record on Tuesday, August 20th were given a $0.458 dividend. The ex-dividend date was Monday, August 19th. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.44. This represents a $1.83 annualized dividend and a yield of 3.39%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 30.40%.
Several equities analysts have recently commented on the company. Morgan Stanley reduced their target price on Walgreens Boots Alliance from $61.00 to $58.00 and set an “equal weight” rating for the company in a research note on Friday, August 23rd. JPMorgan Chase & Co. reduced their target price on Walgreens Boots Alliance from $74.00 to $73.00 and set an “overweight” rating for the company in a research note on Friday, June 28th. Bank of America reduced their target price on Walgreens Boots Alliance from $53.00 to $51.00 and set an “underperform” rating for the company in a research note on Monday, June 3rd. BidaskClub raised Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Wednesday, September 11th. Finally, Zacks Investment Research lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating and set a $53.00 price target on the stock. in a research report on Monday, June 10th. Seven research analysts have rated the stock with a sell rating, eleven have given a hold rating and four have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $63.65.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Recommended Story: What does the Dogs of the Dow mean?
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.